Recruiting
Phase 2

Chemotherapy Reduction

Sponsor:

University of Washington

Code:

NCT06745076

Conditions

Advanced Hodgkin Lymphoma

Classic Hodgkin Lymphoma

Lugano Classification Stage III Hodgkin Lymphoma AJCC v8

Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Dacarbazine

Doxorubicin

Echocardiography

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by University of Washington on 2025-03-10.